Chris Campbell, DPT of Sport and Spine Physical Therapy provides care
for pediatric patients suffering from orthopedic ailments such as post - fracture and joint injuries, basic sprains and strains, growing pains such as Severs and Osgood Schlatters as well as sports injury rehab and management.
Chicago, Ill., July 20, 2016 — AveXis, Inc., a clinical - stage gene therapy company developing treatments
for patients suffering from rare and life - threatening neurological genetic diseases, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation
for AVXS - 101, the company's lead development candidate
for the treatment of spinal muscular atrophy (SMA) Type 1 in
pediatric patients.